This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Immunomedics Inc
IMMU : NASDAQ : Health Care

$4.15 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 840,100
04/24/14 - 4:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
IMMU IMMUNOMEDICS INC 3.99 332.36 n/m 9.80 157.97
DVAX DYNAVAX TECHNOLOGIES CORP 1.50 394.28 n/m 11.25 15.82
PLX PROTALIX BIOTHERAPEUTICS INC 4.18 391.16 n/m 11.51 -66.56
AMAG AMAG PHARMACEUTICALS INC 17.75 386.95 n/m 80.86 -5.30
ZIOP ZIOPHARM ONCOLOGY INC 3.38 339.88 n/m 0.80 0.00
SVA SINOVAC BIOTECH LTD 6.13 337.71 51.08 72.52 47.35
CYTK CYTOKINETICS INC 9.07 327.34 n/m 30.65 305.45
CUR NEURALSTEM INC 3.78 325.90 n/m 0.11 -73.04
PPHM PEREGRINE PHARMACEUTICLS INC 1.69 315.75 n/m 20.18 3.52
SNSS SUNESIS PHARMACEUTICALS INC 5.18 311.29 n/m 7.96 111.93
GERN GERON CORP 1.97 309.09 n/m 1.28 -52.64
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

IMMU Ind Avg S&P 500
n/m 44.27 18.59
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs